Enantia, a Contract Research Organisation (CRO) member of CataloniaBio & HealthTech and specialised in medicinal chemistry, process chemistry and solid form development, has expanded its facilities at the Barcelona Science Park commissioning a new Kilo Lab.

The Kilo Lab is designed for the development, scale up and production of key intermediates and compounds to be used in preclinical phases of the development of a drug.

More information

Photo: Enantia's Kilo Lab - © Barcelona Science Park

You may also be interested in:

• Enantia launches new cannabinoids cocrystal platform
• Enantia presents new website highlighting offering in asymmetrical chemistry and crystallisation technology